Neurocrine Biosciences, Inc.
METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS
Last updated:
Abstract:
Provided are methods of administering a catechol-O-methyltransferase (COMT) inhibitor chosen from opicapone, or a pharmaceutically acceptable salt and/or isotopic variant thereof, to a patient in need thereof wherein the patient is already being administered quinidine or is suffering from a disease or disorder treatable by quinidine.
Status:
Application
Type:
Utility
Filling date:
4 Oct 2019
Issue date:
4 Nov 2021